Cell Culture Technology– category –
-
Argonne National Lab’s ‘OPAL’ Integrates AI and Robotics for Autonomous Protein Design and Biomanufacturing, Strengthening Supply Chains
Argonne National Laboratory (DOE) USA Overview Argonne National Laboratory is developing the 'Orchestrated Platform for Autonomous Laboratories (OPAL),' an AI-driven protein design and humanoid robotics integration. This autonomous 'desi... -
A4BEE Unleashes AI-Powered Agents to Revolutionize Bioreactor Autonomy and Lab Data Management
A4BEE Unknown Overview A4BEE is advancing AI-powered agent technology to drive autonomy in bioprocesses and streamline lab operations. Their 'Bioreactor Growth Agent' provides real-time monitoring and control of bioreactor runs, optimizi... -
FDA Introduces Flexible CMC Guidance for Cell and Gene Therapy Products, Ending ‘Rule of Three’ for Commercial Validation Batches
BioProcess International USA Overview The FDA published and immediately implemented Level 2 guidance, 'CMC Flexibilities for Developing Human Cellular and Gene Therapy Products for a Biologics License Application' on May 5, 2026. This la... -
eXoZymes Selected for DOE’s Genesis Mission to Revolutionize Cell-Free Biomanufacturing with AI-Powered Digital Twins
Stock Titan USA Overview eXoZymes has been chosen for the US Department of Energy's Genesis Mission to advance AI-powered digital twins for cell-free biomanufacturing. The company will leverage hybrid models integrating enzyme kinetics, ... -
Cultivated Meat Regulation Matures Globally: US Federal Approvals, ANZ Standards, and UK Guidance Set New Benchmarks
Dr. Mercola International Overview The global regulatory environment for cultivated meat is rapidly advancing, with five products completing federal review in the US, alongside new cell-cultivated food standards in Australia/New Zealand ... -
Sartorius Drives Bioprocessing Evolution: New Ambr 250 HT and Pionic Modules Fast-Track Cell Therapies and Continuous Manufacturing
Sartorius boerse.de Investing.com Germany Overview Sartorius reported strong H1 2026 growth, largely fueled by new innovations in its Bioprocess Solutions Division. Key launches include the Ambr 250 HT Cell Therapies Vessel, designed for... -
AGC Biologics Secures Landmark Multi-Hundred-Million-Dollar Deal for Yokohama Facility, Cementing Japan’s Biologics Manufacturing Leadership
AGC Biologics Japan Overview AGC Biologics has secured a multi-year, multi-hundred-million-dollar commercial manufacturing agreement for its new Yokohama facility, slated to open in 2027. This landmark deal dedicates approximately half o... -
Experimental Study Illuminates Critical Process Parameters for Human NK Cell Manufacturing, Successfully Builds Statistical Model for Viable Cell Yield Prediction via Design of Experiments
Frontiers International Overview A groundbreaking experimental study, employing Design of Experiments (DoE), has precisely elucidated the impact of Critical Process Parameters (CPPs) on Critical Quality Attributes (CQAs) during human NK ... -
Reusable Bioreactor Market Surges: Driven by Large-Volume Biologics Production and CDMO Capacity Expansion, Hybrid Manufacturing Emerges
Constancy Researchers USA Overview The reusable bioreactor market is experiencing substantial growth, propelled by the increasing demand for large-volume commercial biopharmaceutical production and the expansion of CDMO capacities. A not... -
Perfusion Bioreactor Market Surges Driven by Continuous Biomanufacturing and Intensified Bioprocessing; Thermo Fisher’s DynaDrive Platform Leads
Constancy Researchers USA Overview The perfusion bioreactor market is experiencing rapid growth, primarily fueled by the adoption of continuous biomanufacturing and intensified bioprocessing strategies. Thermo Fisher Scientific's HyPerfo...
